Cynosure, Inc.  

(Public, NASDAQ:CYNO)   Watch this stock  
Find more results for CYNO
24.96
+0.98 (4.09%)
Real-time:   2:59PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.64 - 25.12
52 week 18.37 - 30.20
Open 24.77
Vol / Avg. 277,327.00/196,107.00
Mkt cap 403.58M
P/E 31.52
Div/yield     -
EPS 0.79
Shares 16.17M
Beta 1.87
Inst. own 78%
Jun 24, 2013
Cynosure Inc. Extraordinary Shareholder Meeting Add to calendar
May 21, 2013
Cynosure Inc. at UBS Global Healthcare Conference - Webcast
Apr 30, 2013
Q1 2013 Cynosure Inc. Earnings Conference Call - Webcast
Apr 29, 2013
Q1 2013 Cynosure Inc. Earnings Release
Apr 3, 2013
Cynosure Inc. at the 33rd Annual Scientific Conference of the American Society for Laser Medicine and Surgery (ASLMS)
Mar 18, 2013
Cynosure Inc. Signs Definitive Agreement to Acquire Palomar Medical Technologies - Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 3.04% 7.14%
Operating margin 4.89% 7.90%
EBITD margin - 12.40%
Return on average assets 2.11% 5.68%
Return on average equity 2.50% 6.91%
Employees 378 -
Carbon Disclosure Rating - -

Address

5 Carlisle Road
WESTFORD, MA 01886
United States - Map
+1-978-2564200 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Develops and market aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular lesions and pigmented lesions and temporarily reduce the appearance of cellulite. Their systems incorporate a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag and diode lasers, as well as intense pulsed light. They believe that they are one of only a few companies that currently offer aesthetic treatment systems utilizing Alexandrite and pulse dye lasers, which are particularly well suited for some applications and skin types. The Company offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies.

Officers and directors

Michael R. Davin Chairman of the Board, President, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Timothy W. Baker Chief Financial Officer, Executive Vice President, Treasurer
Age: 51
Bio & Compensation  - Reuters
Douglas J. Delaney Executive Vice President - Sales
Age: 45
Bio & Compensation  - Reuters
Andrea Cangioli Director
Age: 46
Bio & Compensation  - Reuters
Brian M. Barefoot Independent Director
Age: 69
Bio & Compensation  - Reuters
Ettore V. Biagioni Independent Director
Age: 54
Bio & Compensation  - Reuters
Marina Hatsopoulos Independent Director
Age: 46
Bio & Compensation  - Reuters
Thomas H. Robinson Independent Director
Age: 53
Bio & Compensation  - Reuters